07/03/2025
3:15 PM | Coyne Christine (Reporting)
Iterum Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2025
3:16 PM | Coyne Christine (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2025
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2025
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2025
8:11 PM | Iterum Therapeutics (Filer)
| Form 424B5 | |
04/29/2025
8:16 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
7:00 AM | Iterum Therapeutics (Issuer)
Whalen Joseph John (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/10/2025
7:35 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2025
11:15 PM | Iterum Therapeutics (Filer)
| Form EFFECT | |
Get the Latest News and Ratings for ITRM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/14/2025
4:36 PM | ARMISTICE CAPITAL, LLC (Filed by)
Iterum Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/07/2025
3:33 PM | Iterum Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/07/2025
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/23/2025
5:30 PM | HUNT RONALD (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
5:30 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
6:04 AM | Iterum Therapeutics (Filer)
| Form 424B5 | |
11/21/2024
8:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
6:54 PM | Iterum Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
4:10 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
5:24 AM | Iterum Therapeutics (Filer)
| Form 424B5 | |
10/28/2024
5:06 AM | Iterum Therapeutics (Filer)
| Form 424B5 | |
10/25/2024
10:20 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
7:00 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
8:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
4:20 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
3:15 PM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/30/2024
6:30 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/24/2024
7:59 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/24/2024
8:01 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/23/2024
5:30 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/11/2024
3:50 PM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/09/2024
5:15 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
08/14/2024
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
11:15 PM | Iterum Therapeutics (Filer)
| Form EFFECT | |
08/12/2024
8:00 AM | HUNT RONALD (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
8:00 AM | Fishman Corey N. (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
I was wrong about Trump (Ad) I made a mistake.
A mistake I feel very foolish about.
After speaking with Donald Trump and some of his advisors, I believed him.
I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years.
But I was wrong. Let me show you exactly what we’re doing to prepare. |
08/12/2024
8:00 AM | Dunne Michael W. (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
4:28 PM | Iterum Therapeutics (Filer)
| Form POS AM | |
08/06/2024
4:25 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2024
3:30 PM | Iterum Therapeutics (Filer)
| Form PRE 14A | |
07/22/2024
7:30 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2024
11:15 PM | Iterum Therapeutics (Filer)
| Form EFFECT | |
07/19/2024
4:05 PM | Iterum Therapeutics (Filer)
| Form 424B3 | |
07/17/2024
3:21 PM | Iterum Therapeutics (Filer)
| Form S-1/A | |
Free ITRM Stock Alerts